← Back

Wire · operational-macro

Where private equity is finding value in MedTech

Published

18 September 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at mcdermottlaw.com →

◆ Verified

Fusion42 · 19 September 2026 · Fusion42 review

Private equity investment in MedTech is concentrating in fewer, larger deals focused on fast-growing categories like cardiovascular care and neurostimulation. Strategies include carve-outs and take-private transactions that require disciplined diligence to manage operational, regulatory, and execution risks.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Private equity is reshaping MedTech by backing bigger deals in high-growth areas, creating openings for entrepreneurs to align with PE-backed carve-outs or take-privates. You need to sharpen your diligence on regulatory and operational dependencies to stand out in this more selective market.

◆ Coverage

1 source · 18 Sep 2026

◆ Related on Wire

◆ Topics

Medtechprivate-equitymedtechm-acarve-outstake-privatesinvestment-trends